JP2003517041A5 - - Google Patents

Download PDF

Info

Publication number
JP2003517041A5
JP2003517041A5 JP2001545542A JP2001545542A JP2003517041A5 JP 2003517041 A5 JP2003517041 A5 JP 2003517041A5 JP 2001545542 A JP2001545542 A JP 2001545542A JP 2001545542 A JP2001545542 A JP 2001545542A JP 2003517041 A5 JP2003517041 A5 JP 2003517041A5
Authority
JP
Japan
Prior art keywords
nucleotide sequence
seq
phosphodiester nucleotide
synthetic phosphodiester
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001545542A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003517041A (ja
JP4772245B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2000/001467 external-priority patent/WO2001044465A2/en
Publication of JP2003517041A publication Critical patent/JP2003517041A/ja
Publication of JP2003517041A5 publication Critical patent/JP2003517041A5/ja
Application granted granted Critical
Publication of JP4772245B2 publication Critical patent/JP4772245B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001545542A 1999-12-13 2000-12-12 治療上有用な合成オリゴヌクレオチド Expired - Fee Related JP4772245B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17032599P 1999-12-13 1999-12-13
US60/170,325 1999-12-13
US22892500P 2000-08-29 2000-08-29
US60/228,925 2000-08-29
PCT/CA2000/001467 WO2001044465A2 (en) 1999-12-13 2000-12-12 Therapeutically useful synthetic oligonucleotides

Publications (3)

Publication Number Publication Date
JP2003517041A JP2003517041A (ja) 2003-05-20
JP2003517041A5 true JP2003517041A5 (cg-RX-API-DMAC7.html) 2008-02-07
JP4772245B2 JP4772245B2 (ja) 2011-09-14

Family

ID=26865979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001545542A Expired - Fee Related JP4772245B2 (ja) 1999-12-13 2000-12-12 治療上有用な合成オリゴヌクレオチド

Country Status (18)

Country Link
US (2) US7157436B2 (cg-RX-API-DMAC7.html)
EP (2) EP1867718B1 (cg-RX-API-DMAC7.html)
JP (1) JP4772245B2 (cg-RX-API-DMAC7.html)
KR (1) KR100829646B1 (cg-RX-API-DMAC7.html)
CN (2) CN100445380C (cg-RX-API-DMAC7.html)
AT (2) ATE370231T1 (cg-RX-API-DMAC7.html)
AU (1) AU785212B2 (cg-RX-API-DMAC7.html)
CA (1) CA2393808A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20022372A3 (cg-RX-API-DMAC7.html)
DE (2) DE60036019T2 (cg-RX-API-DMAC7.html)
DK (2) DK1238070T3 (cg-RX-API-DMAC7.html)
ES (2) ES2288883T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0300627A3 (cg-RX-API-DMAC7.html)
IL (2) IL150196A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02005842A (cg-RX-API-DMAC7.html)
NO (1) NO330508B1 (cg-RX-API-DMAC7.html)
PT (1) PT1238070E (cg-RX-API-DMAC7.html)
WO (1) WO2001044465A2 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030032610A1 (en) 1996-06-03 2003-02-13 Gilchrest Barbara A. Method to inhibit cell growth using oligonucleotides
US8114850B2 (en) 1999-04-08 2012-02-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US7960540B2 (en) 1999-04-08 2011-06-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
PT1181304E (pt) 1999-04-08 2008-01-23 Antisoma Res Ltd Actividade antiproliferativa de oligonucleótidos ricos em g e método de utilização dos mesmos para ligação a nucleolina
US6949520B1 (en) * 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
DE60036019T2 (de) * 1999-12-13 2008-05-29 Bioniche Life Sciences Inc., Belleville Synthetische oligonukleotide die therapeutisch nützlich sind
JP2004507469A (ja) 2000-08-29 2004-03-11 バイオニケ ライフ サイエンシーズ インコーポレイテッド Fasおよびfasl発現の調整
WO2002069369A2 (en) * 2000-12-08 2002-09-06 Coley Pharmaceutical Gmbh Cpg-like nucleic acids and methods of use thereof
US7087586B2 (en) * 2001-04-24 2006-08-08 Bioniche Life Sciences, Inc. Oligonucleotide compositions and their use to induce differentiation of cells
DE60211206T2 (de) * 2001-08-17 2006-10-26 Bioniche Life Sciences Inc., Belleville Zusammenhang zwischen konformation und biologischer aktivität von apoptose induzierenden phosphodiesteroligonukleotiden
IL161181A0 (en) 2001-10-03 2004-08-31 Bioniche Life Sciences Inc Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
CN101160399A (zh) * 2002-04-22 2008-04-09 拜奥尼茨生命科学公司 寡核苷酸组合物及其在调节免疫应答中的应用
EP1608403A2 (en) * 2003-04-02 2005-12-28 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations for topical application
KR20060012622A (ko) * 2003-05-16 2006-02-08 하이브리돈, 인코포레이티드 화학요법제와 함께 이뮤노머를 사용하는 상승적 암 치료방법
WO2006091915A2 (en) * 2005-02-24 2006-08-31 Coley Pharmaceutical Group, Inc. Immunostimulatory oligonucleotides
EP1863538A4 (en) * 2005-03-09 2009-01-14 Baylor College Medicine DIRECT INVERSION OF CD4 + T CELL LYMPHOCYTE INHIBITOR FUNCTION VIA TOLL-TYPE 8 RECEIVER SIGNALING
GB2443591B (en) * 2005-09-07 2010-04-28 Secr Defence Adjuvanted vaccine
JP6066035B2 (ja) * 2009-02-12 2017-01-25 クルナ・インコーポレーテッド グリア細胞由来神経栄養因子(gdnf)関連疾病の、gdnfに対する天然アンチセンス転写物の抑制による治療
GB0906234D0 (en) 2009-04-14 2009-05-20 Secr Defence Vaccine
KR100998365B1 (ko) 2009-06-29 2010-12-06 압타바이오 주식회사 치료 효능이 있는 변형핵산 및 구아노신을 함유하는 올리고뉴클레오티드 변형체
EP2490767A4 (en) * 2009-07-15 2013-02-13 Santaris Pharma As OBJECTIVE RNA ANTAGONISTS FOR THE TREATMENT OF LEUKEMIA ON GLI2
EP2821504A4 (en) * 2012-02-28 2016-02-17 Univ Tokyo Nat Univ Corp METHOD FOR DETERMINING A DISEASE RELATED TO TDP-43 CONCENTRATION IN CELLS
EP4000597A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
WO2023122762A1 (en) * 2021-12-22 2023-06-29 Camp4 Therapeutics Corporation Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnas

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
FR2160326B1 (cg-RX-API-DMAC7.html) * 1971-11-19 1975-02-07 Anvar
US4152423A (en) * 1971-11-19 1979-05-01 Agence Nationale De Valorisation De La Recherche (Anvar) Immunological agents
CA1020460A (en) * 1973-02-23 1977-11-08 Wellcome Foundation Limited (The) Isolation of immunostimulating glycopeptide from bacteria
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2374042A1 (fr) * 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
JPS54140710A (en) * 1978-03-10 1979-11-01 Mitsui Toatsu Chem Inc Anti-tumor substance and its preparation
DE3011461C2 (de) * 1980-03-25 1986-10-30 Dr. Madaus & Co, 5000 Köln Verwendung von Propionibakterien
US4520019A (en) * 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4579941A (en) * 1982-08-13 1986-04-01 Mitsuitoatsu Chemicals, Inc. Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent
US4663306A (en) * 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
DE3423234A1 (de) * 1984-06-23 1986-02-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Synergistische mischungen von interferonen und tumor-nekrose-faktor
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
DE3723075A1 (de) * 1987-07-11 1989-01-19 Boehringer Mannheim Gmbh Eukaryotische expressionsvektoren mit multimeren enhancer-subelementen, verfahren zu ihrer herstellung und verwendung
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
WO1992007095A1 (en) * 1990-10-15 1992-04-30 Stratagene Arbitrarily primed polymerase chain reaction method for fingerprinting genomes
IL101038A0 (en) * 1991-02-21 1992-11-15 Gilead Sciences Inc Agent specific for trombin and its use
EP0952855B1 (en) * 1991-07-03 2005-07-27 Meditech Research Limited Use of hyaluronan in gene therapy
US5582981A (en) * 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
IL107150A0 (en) * 1992-09-29 1993-12-28 Isis Pharmaceuticals Inc Oligonucleotides having a conserved g4 core sequence
AU691797B2 (en) * 1993-01-29 1998-05-28 Vetrepharm, Inc. Immunotherapeutic composition
US5567604A (en) * 1993-04-23 1996-10-22 Aronex Pharmaceuticals, Inc. Anti-viral guanosine-rich oligonucleotides
CN1154702A (zh) * 1994-05-25 1997-07-16 海布里登公司 具有抗巨细胞病毒活性的寡核苷酸
DE69533037T2 (de) * 1994-08-30 2005-05-04 Commonwealth Scientific And Industrial Research Organisation Pflanzentraskriptionsregulator von circovirus
US5643890A (en) 1995-01-31 1997-07-01 The Board Of Regents Of The University Of Nebraska Synthetic oligonucleotides which mimic telomeric sequences for use in treatment of cancer and other diseases
IN181358B (cg-RX-API-DMAC7.html) * 1995-02-14 1998-05-30 Bioniche Inc
ZA964446B (en) * 1995-06-06 1996-12-06 Hoffmann La Roche Oligonucleotides specific for hepatitis c virus
US5990299A (en) * 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
CN1202900A (zh) * 1995-11-21 1998-12-23 Icn药品公司 用il-8和il-8受体的反义寡核苷酸抑制肿瘤生长
IT1277025B1 (it) * 1995-12-04 1997-11-04 Cooperativa Centro Ricerche Po Classe di oligonucleotidi fosfodiesterici ad attivita' citotossica composizioni farmaceutiche che li contengono e loro uso
US6015710A (en) * 1996-04-09 2000-01-18 The University Of Texas System Modulation of mammalian telomerase by peptide nucleic acids
WO1997044064A2 (en) * 1996-05-20 1997-11-27 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Oligonucleotides which specifically bind retroviral nucleocapsid proteins
KR100533576B1 (ko) * 1997-08-05 2005-12-05 바이오니취 라이프 사이언시즈 인코포레이티드 세포증식 및 세포사멸 조절용 조성물 및 방법
US6255473B1 (en) * 1997-08-29 2001-07-03 Duke University Presenilin-1 gene promoter
WO2001022972A2 (en) * 1999-09-25 2001-04-05 University Of Iowa Research Foundation Immunostimulatory nucleic acids
DE60036019T2 (de) * 1999-12-13 2008-05-29 Bioniche Life Sciences Inc., Belleville Synthetische oligonukleotide die therapeutisch nützlich sind
US20020091095A1 (en) * 1999-12-13 2002-07-11 Phillips Nigel C. Modulation of Fas and FasL expression
US7125858B2 (en) * 1999-12-28 2006-10-24 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
IL161181A0 (en) * 2001-10-03 2004-08-31 Bioniche Life Sciences Inc Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
CN101160399A (zh) * 2002-04-22 2008-04-09 拜奥尼茨生命科学公司 寡核苷酸组合物及其在调节免疫应答中的应用

Similar Documents

Publication Publication Date Title
NZ522326A (en) Adenosine A2A receptor antagonists
JP2002535332A5 (cg-RX-API-DMAC7.html)
JP2002532222A5 (cg-RX-API-DMAC7.html)
HUP0300527A3 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
AU2001280597A1 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
JP2002510633A5 (cg-RX-API-DMAC7.html)
EP1074549A3 (en) Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
IL155966A0 (en) Benzothiophene derivative compounds, process of preparation and use thereof
AU2002305236A8 (en) Composition, formulations and kits for treatment of respiratory and lung disease with anti-sense oligonucleotides and a bronchodilating agent
HK1052346A1 (zh) 有效用作β-2-肾上腺素受体激动剂以及PDE4-抑制剂的化合物
ZA200106102B (en) Use of growth hormone secretagogues for improvement of functional health status.
ZA200105293B (en) Use of growth hormone secretagogues for treatment of physical performance decline.
AU2001264044A1 (en) 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
JP2002522501A5 (cg-RX-API-DMAC7.html)
JP2002506864A5 (cg-RX-API-DMAC7.html)
GB0110061D0 (en) Novel 4,5-Dihydroisoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor and preparation thereof
JP2002540769A5 (cg-RX-API-DMAC7.html)
HUP0204554A3 (en) Endoparasiticidal composition, preparation and use thereof
USD449421S1 (en) Woman's necktie
CA2353205A1 (en) Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
MXPA03004498A (es) Uso de pirazolo (4,3-d)pirimidinas.
ZA985277B (en) Novel ß-amino and ß-azido carboxylic and acid derivatives, their preparation and use as endothelin receptor antagonists.
JP2003516751A5 (cg-RX-API-DMAC7.html)
AU2002240248A1 (en) Expandable, no-shrink shirt collar
USD460840S1 (en) Horse head collar